Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced, Resectable”

320 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 320 results

Testing effectiveness (Phase 2)Study completedNCT00043108
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Fox Chase Cancer Center 19
Testing effectiveness (Phase 2)UnknownNCT03288350
What this trial is testing

MDCF + Avelumab in Resectable Esophago-gastric Adenocarcinoma (EGA)

Who this might be right for
Gastric AdenocarcinomaEsophageal Adenocarcinoma
McGill University Health Centre/Research Institute of the McGill University Health Centre 55
Testing effectiveness (Phase 2)UnknownNCT02948348
What this trial is testing

Study to Nivolumab Following Preoperative Chemoradiotherapy

Who this might be right for
Cancer of Rectum
Takayuki Yoshino 90
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Early research (Phase 1)UnknownNCT03843515
What this trial is testing

Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Amsterdam UMC, location VUmc 17
Testing effectiveness (Phase 2)UnknownNCT04289792
What this trial is testing

Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Fujian Medical University Union Hospital 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04846634
What this trial is testing

Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)

Who this might be right for
Resectable Locally Advanced Non-small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06508229
What this trial is testing

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Harbin Medical University 65
Testing effectiveness (Phase 2)UnknownNCT04982939
What this trial is testing

Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric Cancer

Who this might be right for
Gastric CancerPerioperativeSintilimab
Tianjin Medical University Cancer Institute and Hospital 210
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06554028
What this trial is testing

Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer

Who this might be right for
Laryngeal CancerHypopharynx CancerLaryngeal Neoplasms
Henan Cancer Hospital 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06389500
What this trial is testing

HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Harbin Medical University 30
Testing effectiveness (Phase 2)UnknownNCT01237665
What this trial is testing

IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer

Who this might be right for
Rectal Cancer
Ottawa Hospital Research Institute 15
Large-scale testing (Phase 3)Ended earlyNCT01836432
What this trial is testing

Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Carcinoma Non-resectableLocally Advanced Malignant Neoplasm
NewLink Genetics Corporation 302
Testing effectiveness (Phase 2)Looking for participantsNCT07069712
What this trial is testing

Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Who this might be right for
Gastroesophageal Adenocarcinoma
AstraZeneca 100
Large-scale testing (Phase 3)Study completedNCT01099436
What this trial is testing

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Borstkanker Onderzoek Groep 250
Testing effectiveness (Phase 2)Study completedNCT01152710
What this trial is testing

Capecitabine as Radiosensitising Agent in Neoadjuvant Treatment of Locally Advanced Resectable Rectal Cancer

Who this might be right for
Resectable Rectal Cancer Clinical Stage II and III
Institute of Oncology Ljubljana 57
Testing effectiveness (Phase 2)UnknownNCT01091376
What this trial is testing

Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 75
Testing effectiveness (Phase 2)Study completedNCT03496662
What this trial is testing

BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Washington University School of Medicine 40
Large-scale testing (Phase 3)UnknownNCT03223740
What this trial is testing

Preoperative Stomach Cancer Induction Chemotherapy and Radiation Therapy

Who this might be right for
Locally Advanced Gastric Carcinoma
Sichuan Provincial People's Hospital 450
Testing effectiveness (Phase 2)Study completedNCT01635270
What this trial is testing

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more
Centre Leon Berard 54
Load More Results